Fra-1 a target for cancer prevention or intervention - PubMed (original) (raw)
Review
Fra-1 a target for cancer prevention or intervention
Matthew R Young et al. Gene. 2006.
Abstract
The transcription factor activator protein-1 (AP-1) has been implicated as a driver of carcinogenesis since its original characterization. Oncogenic transcription factors like AP-1 are becoming new targets for cancer intervention. Inhibitors of AP-1 have been shown to block tumor promotion, transformation, progression and invasion. The Fos related antigen-1 (Fra-1) is activated in multiple cancers and gene ablation can suppress the invasive phenotypes of many tumor cell lines. This review focuses on the regulation of fosl1 expression, stabilization and activation of the Fra-1 polypeptide and on Fra-1-mediated tumorigenesis.
Similar articles
- High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
Zoumpourlis V, Papassava P, Linardopoulos S, Gillespie D, Balmain A, Pintzas A. Zoumpourlis V, et al. Oncogene. 2000 Aug 17;19(35):4011-21. doi: 10.1038/sj.onc.1203732. Oncogene. 2000. PMID: 10962557 - The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas.
Milde-Langosch K, Röder H, Andritzky B, Aslan B, Hemminger G, Brinkmann A, Bamberger CM, Löning T, Bamberger AM. Milde-Langosch K, et al. Breast Cancer Res Treat. 2004 Jul;86(2):139-52. doi: 10.1023/B:BREA.0000032982.49024.71. Breast Cancer Res Treat. 2004. PMID: 15319566 - Genome-wide profiling of AP-1-regulated transcription provides insights into the invasiveness of triple-negative breast cancer.
Zhao C, Qiao Y, Jonsson P, Wang J, Xu L, Rouhi P, Sinha I, Cao Y, Williams C, Dahlman-Wright K. Zhao C, et al. Cancer Res. 2014 Jul 15;74(14):3983-94. doi: 10.1158/0008-5472.CAN-13-3396. Epub 2014 May 15. Cancer Res. 2014. PMID: 24830720 - Fos family members: regulation, structure and role in oncogenic transformation.
Tulchinsky E. Tulchinsky E. Histol Histopathol. 2000 Jul;15(3):921-8. doi: 10.14670/HH-15.921. Histol Histopathol. 2000. PMID: 10963134 Review. - Role of Fra-2 in cancer.
Rampioni Vinciguerra GL, Capece M, Scafetta G, Rentsch S, Vecchione A, Lovat F, Croce CM. Rampioni Vinciguerra GL, et al. Cell Death Differ. 2024 Feb;31(2):136-149. doi: 10.1038/s41418-023-01248-4. Epub 2023 Dec 16. Cell Death Differ. 2024. PMID: 38104183 Free PMC article. Review.
Cited by
- Global Impairment of Immediate-Early Genes Expression in Rett Syndrome Models and Patients Linked to Myelination Defects.
Petazzi P, Jorge-Torres OC, Gomez A, Scognamiglio I, Serra-Musach J, Merkel A, Grases D, Xiol C, O'Callaghan M, Armstrong J, Esteller M, Guil S. Petazzi P, et al. Int J Mol Sci. 2023 Jan 11;24(2):1453. doi: 10.3390/ijms24021453. Int J Mol Sci. 2023. PMID: 36674969 Free PMC article. - Widespread FRA1-dependent control of mesenchymal transdifferentiation programs in colorectal cancer cells.
Diesch J, Sanij E, Gilan O, Love C, Tran H, Fleming NI, Ellul J, Amalia M, Haviv I, Pearson RB, Tulchinsky E, Mariadason JM, Sieber OM, Hannan RD, Dhillon AS. Diesch J, et al. PLoS One. 2014 Mar 21;9(3):e88950. doi: 10.1371/journal.pone.0088950. eCollection 2014. PLoS One. 2014. PMID: 24658684 Free PMC article. - Cell invasion through basement membrane: the anchor cell breaches the barrier.
Hagedorn EJ, Sherwood DR. Hagedorn EJ, et al. Curr Opin Cell Biol. 2011 Oct;23(5):589-96. doi: 10.1016/j.ceb.2011.05.002. Epub 2011 May 31. Curr Opin Cell Biol. 2011. PMID: 21632231 Free PMC article. Review. - Prioritizing drug targets by perturbing biological network response functions.
Perrone MC, Lerner MG, Dunworth M, Ewald AJ, Bader JS. Perrone MC, et al. PLoS Comput Biol. 2024 Jun 27;20(6):e1012195. doi: 10.1371/journal.pcbi.1012195. eCollection 2024 Jun. PLoS Comput Biol. 2024. PMID: 38935814 Free PMC article. - Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties.
Oliveira-Ferrer L, Kürschner M, Labitzky V, Wicklein D, Müller V, Lüers G, Schumacher U, Milde-Langosch K, Schröder C. Oliveira-Ferrer L, et al. J Cancer Res Clin Oncol. 2015 Oct;141(10):1715-26. doi: 10.1007/s00432-015-1925-2. Epub 2015 Feb 10. J Cancer Res Clin Oncol. 2015. PMID: 25666264
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials